Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 34 Records) |
| Query Trace: Disease and SRD5A2[original query] |
|---|
| SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness. The Prostate 2007 Nov 67 (15): 1654-63. Neslund-Dudas Christine, Bock Cathryn H, Monaghan Kristin, Nock Nora L, Yang James J, Rundle Andrew, Tang Deliang, Rybicki Benjamin |
| Inherited variation in hormone-regulating genes and prostate cancer survival. Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Sep 13 (17): 5156-61. Lindström Sara, Adami Hans-Olov, Bälter Katarina Augustsson, Xu Jianfeng, Zheng S Lilly, Stattin Pär, Grönberg Henrik, Wiklund Fredr |
| Evaluation of genetic variations in the androgen and estrogen metabolic pathways as risk factors for sporadic and familial prostate cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007 May 16 (5): 969-78. Cunningham Julie M, Hebbring Scott J, McDonnell Shannon K, Cicek Mine S, Christensen G Bryce, Wang Liang, Jacobsen Steven J, Cerhan James R, Blute Michael L, Schaid Daniel J, Thibodeau Stephen |
| The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer. The Prostate 2008 Dec 68 (16): 1798-805. Scariano John K, Treat Eric, Alba Frances, Nelson Harold, Ness Scott A, Smith Anthony |
| Role of hormonal genes and risk of prostate cancer: gene-gene interactions in a North Indian population. Cancer genetics and cytogenetics 2008 Sep 185 (2): 78-85. Sobti R C, Gupta L, Singh S K, Seth A, Kaur P, Thakur |
| The interaction of CYP3A5 polymorphisms along the androgen metabolism pathway in prostate cancer. International journal of cancer. Journal international du cancer 2008 Jun 122 (11): 2511-6. Vaarala Markku H, Mattila Henna, Ohtonen Pasi, Tammela Teuvo L J, Paavonen Timo K, Schleutker Johan |
| V89L polymorphism of the 5alpha-reductase Type II gene (SRD5A2), endogenous sex hormones, and prostate cancer risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008 Feb 17 (2): 286-91. Boger-Megiddo Inbal, Weiss Noel S, Barnett Matt J, Goodman Gary E, Chen C |
| Polymorphisms of steroid 5-alpha-reductase type I (SRD5A1) gene are associated to peripheral arterial disease. Journal of endocrinological investigation 2008 Dec 31 (12): 1092-7. Signorelli S S, Barresi V, Musso N, Anzaldi M, Croce E, Fiore V, Condorelli D |
| Effect of puberty onset on spontaneous hepatitis B virus e antigen seroconversion in men. Gastroenterology 2010 Mar 138 (3): 942-8.e1. Wu Jia-Feng, Tsai Wen-Yu, Hsu Hong-Yuan, Ni Yen-Hsuan, Chen Huey-Ling, Tsuei Daw-Jen, Chang Mei-Hw |
| Steroid 5-{alpha}-reductase Type 2 (SRD5a2) gene polymorphisms and risk of prostate cancer: a HuGE review. American journal of epidemiology 2010 Jan 171 (1): 1-13. Li Jun, Coates Ralph J, Gwinn Marta, Khoury Muin |
| Genetics of hypospadias: are single-nucleotide polymorphisms in SRD5A2, ESR1, ESR2, and ATF3 really associated with the malformation? The Journal of clinical endocrinology and metabolism 2010 May 95 (5): 2384-90. van der Zanden Loes F M, van Rooij Iris A L M, Feitz Wout F J, Vermeulen Sita H H M, Kiemeney Lambertus A L M, Knoers Nine V A M, Roeleveld Nel, Franke Barba |
| Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010 Jan 19 (1): 1. Setlur Sunita R, Chen Chen X, Hossain Ruhella R, Ha Jung Sook, Van Doren Vanessa E, Stenzel Birgit, Steiner Eberhard, Oldridge Derek, Kitabayashi Naoki, Banerjee Samprit, Chen Jin Yun, Schäfer Georg, Horninger Wolfgang, Lee Charles, Rubin Mark A, Klocker Helmut, Demichelis Frances |
| Genotyping of sex hormone-related pathways in benign and malignant human prostate tissues: data of a preliminary study. Omics : a journal of integrative biology 2011 Jun 15 (6): 369-74. Balistreri Carmela Rita, Caruso Calogero, Carruba Giuseppe, Miceli Vitale, Candore Giuseppi |
| Molecular markers in key steroidogenic pathways, circulating steroid levels, and prostate cancer progression. Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Feb 19 (3): 699-709. Lévesque Éric, Huang Shu-Pin, Audet-Walsh Étienne, Lacombe Louis, Bao Bo-Ying, Fradet Yves, Laverdière Isabelle, Rouleau Mélanie, Huang Chao-Yuan, Yu Chia-Cheng, Caron Patrick, Guillemette Chant |
| Androgen Metabolism Gene Polymorphisms, Associations with Prostate Cancer Risk and Pathological Characteristics: A Comparative Analysis between South African and Senegalese Men. Prostate cancer 2012 2012 . Fernandez P, Zeigler-Johnson CM, Spangler E, van der Merwe A, Jalloh M, Gueye SM, Rebbeck TR |
| Mutation analysis of the SRD5A2, AR and SF-1 genes in 52 Chinese boys with hypospadias. Journal of pediatric endocrinology & metabolism : JPEM 2013 26 (9-10): 887-93. Wang Ruifang, Dong Zhiya, Wang Wei, Xiao Yuan, Ni Jihong, Wang Def |
| Association of a tagging single nucleotide polymorphism in the androgen receptor gene region with susceptibility to severe hypospadias in a Caucasian population. Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation 2013 7 (4): 173-9. Adamovic T, Thai H T T, Liedén A, Nordenskjöld |
| Genetic variations in genes involved in testosterone metabolism are associated with prostate cancer progression: A Spanish multicenter study. Urologic oncology 2015 Jul 33 (7): 331.e1-7. Henríquez-Hernández Luis Alberto, Valenciano Almudena, Foro-Arnalot Palmira, Álvarez-Cubero María Jesús, Cozar José Manuel, Suárez-Novo José Francisco, Castells-Esteve Manel, Fernández-Gonzalo Pablo, De-Paula-Carranza Belén, Ferrer Montse, Guedea Ferrán, Sancho-Pardo Gemma, Craven-Bartle Jordi, Ortiz-Gordillo María José, Cabrera-Roldán Patricia, Rodríguez-Melcón Juan Ignacio, Herrera-Ramos Estefanía, Rodríguez-Gallego Carlos, Lara Pedro |
| Polymorphisms in androgen metabolism genes AR, CYP1B1, CYP19, and SRD5A2and prostate cancer risk and aggressiveness in Bulgarian patients. Turkish journal of medical sciences 2016 46 (3): 626-40. Kachakova Darina, Mitkova Atanaska, Popov Elenko, Beltcheva Olga, Vlahova Alexandrina, Dikov Tihomir, Christova Svetlana, Mitev Vanio, Slavov Chavdar, Kaneva Rad |
| Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial. Cancer 2016 May . Price Douglas K, Chau Cindy H, Till Cathee, Goodman Phyllis J, Leach Robin J, Johnson-Pais Teresa L, Hsing Ann W, Hoque Ashraful, Parnes Howard L, Schenk Jeannette M, Tangen Catherine M, Thompson Ian M, Reichardt Juergen K V, Figg William |
| Association of SRD5A2 gene mutations with risk of hypospadias in the Iranian population. Journal of endocrinological investigation 2016 Nov . Rahimi M, Ghanbari M, Fazeli Z, Rouzrokh M, Omrani S, Mirfakhraie R, Omrani M |
| Association between SRD5A2 rs523349 and rs9282858 Polymorphisms and Risk of Benign Prostatic Hyperplasia: A Meta-Analysis. Frontiers in physiology 2017 8 688. Zeng Xian-Tao, Su Xin-Jun, Li Sheng, Weng Hong, Liu Tong-Zu, Wang Xing-Hu |
| Genetic Link Between Gender Dysphoria and Sex Hormone Signaling. The Journal of clinical endocrinology and metabolism 2018 Sep . Foreman Madeleine, Hare Lauren, York Kate, Balakrishnan Kara, Sánchez Francisco J, Harte Fintan, Erasmus Jaco, Vilain Eric, Harley Vincent |
| Single-nucleotide and copy-number variance related to severity of hypospadias. Pediatric surgery international 2018 Aug . Singh Neetu, Gupta Devendra Kumar, Sharma Shilpa, Sahu Dinesh Kumar, Mishra Archana, Yadav Devendra Kumar, Rawat Jiledar, Singh Arun Kum |
| Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors. Journal of the National Comprehensive Cancer Network : JNCCN 2018 Mar 16 (3): 257-265. Zaid Mohammad Abu, Gathirua-Mwangi Wambui G, Fung Chunkit, Monahan Patrick O, El-Charif Omar, Williams Annalynn M, Feldman Darren R, Hamilton Robert J, Vaughn David J, Beard Clair J, Cook Ryan, Althouse Sandra K, Ardeshir-Rouhani-Fard Shirin, Dinh Paul C, Sesso Howard D, Einhorn Lawrence H, Fossa Sophie D, Travis Lois B, |
| 5?-Reductase type 2 deficiency in families from an isolated Andean population in Venezuela. Annals of human genetics 2019 10 84 (2): 151-160. Avendaño Andrea, González-Coira Mercedes, Paradisi Irene, Rojas Ascanio, Da Silva Gloria, Gómez-Pérez Roald, Ceballos Jesús Osu |
| Association of Testosterone Levels and Steroid 5-Alpha-Reductase 2 Polymorphisms with Opioid Craving. Neuropsychobiology 2020 Jul 1-10. Janke Eva, Groh Adrian, Mühle Christiane, Dürsteler-MacFarland Kenneth M, Wiesbeck Gerhard A, Kornhuber Johannes, Jahn Kirsten, Groeschl Michael, Lichtinghagen Ralf, Frieling Helge, Bleich Stefan, Hillemacher Thomas, Lenz Bernd, Heberlein Annemar |
| Prostate Cancer Mortality Associated with Aggregate Polymorphisms in Androgen-Regulating Genes: The Atherosclerosis Risk in the Communities (ARIC) Study. Cancers 2021 4 13 (8): . Prizment Anna E, McSweeney Sean, Pankratz Nathan, Joshu Corinne E, Hwang Justin H, Platz Elizabeth A, Ryan Charles |
| A common germline variant in CYP11B1 is associated with adverse clinical outcome of treatment with abiraterone or enzalutamide. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 11 169 115890. Stefan A J Buck, Marinda Meertens, Frederiek M F van Ooijen, Esther Oomen-de Hoop, Evert de Jonge, Marieke J H Coenen, Andries M Bergman, Stijn L W Koolen, Ronald de Wit, Alwin D R Huitema, Ron H N van Schaik, Ron H J Mathijss |
| Body composition as a determinant of the therapeutic index with androgen signaling inhibition. Prostate cancer and prostatic diseases 2024 7 . Andrew W Hahn, Rebecca S Tidwell, Patrick G Pilie, Yao Yu, Jingjing Liu, Devaki Shilpa Surasi, Mark Titus, Jianhua Zhang, Neha Venkatesh, Theocharis Panaretakis, Justin R Gregg, Amado J Zurita, Bilal A Siddiqui, Paul G Corn, Sumit K Subudhi, Pavlos Msaouel, Efstratios Koutroumpakis, Chad D Huff, Ana Aparicio, Jennifer L McQuade, Daniel E Frigo, Christopher J Logothet |
- Page last reviewed:Feb 1, 2024
- Content source: